Compare ASMB & TRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ASMB | TRTX |
|---|---|---|
| Founded | 2005 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 512.1M | 471.4M |
| IPO Year | 2010 | 2015 |
| Metric | ASMB | TRTX |
|---|---|---|
| Price | $20.29 | $6.24 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 6 |
| Target Price | ★ $52.00 | $9.54 |
| AVG Volume (30 Days) | 202.1K | ★ 1.4M |
| Earning Date | 11-09-2026 | 10-26-2026 |
| Dividend Yield | N/A | ★ 16.41% |
| EPS Growth | ★ 91.78 | N/A |
| EPS | N/A | ★ 0.19 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $10.31 |
| P/E Ratio | ★ N/A | $30.71 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $19.94 | $5.57 |
| 52 Week High | $39.71 | $9.37 |
| Indicator | ASMB | TRTX |
|---|---|---|
| Relative Strength Index (RSI) | 31.31 | 46.61 |
| Support Level | N/A | $5.57 |
| Resistance Level | $30.36 | $8.74 |
| Average True Range (ATR) | 1.10 | 0.21 |
| MACD | 0.10 | 0.07 |
| Stochastic Oscillator | 7.07 | 87.59 |
Assembly Biosciences Inc is a clinical-stage biotechnology company. The Company's pipeline includes multiple clinical-stage investigational therapies, including: (1) two long-acting helicase-primase inhibitors (HPI) for the treatment of recurrent genital herpes; (2) an orally bioavailable hepatitis delta virus entry inhibitor; and (3) a potent next-generation capsid assembly modulator designed to disrupt the replication cycle of hepatitis B virus (HBV) at several key points. The Company's pipeline also includes a novel, oral broad-spectrum non-nucleoside polymerase inhibitor (NNPI) for the treatment of transplant-related herpesviruses.
TPG RE Finance Trust Inc is a commercial real estate finance company. It originates, acquires, and manages commercial mortgage loans and other commercial real estate-related debt instruments consisting of first mortgage loans and senior participation interests in first mortgage loans secured by institutional-quality properties in primary and select secondary markets in the United States. The company's objective is to provide attractive risk-adjusted returns to its stockholders over time through cash distributions and capital appreciation. It focuses on directly originating and selectively acquiring floating-rate first mortgage loans that are secured by high-quality commercial real estate properties undergoing some form of transition and value creation.